Donor lymphocyte infusion leads to diversity of specific T cell responses and reduces regulatory T cell frequency in clinical responders
Autor: | Donald Bunjes, Hartmut Döhner, Susanne Hofmann, Michael Schmitt, Jochen Greiner, M Wiesneth, Marlies Götz |
---|---|
Rok vydání: | 2018 |
Předmět: |
Cancer Research
Regulatory T cell business.industry ELISPOT T cell Donor lymphocyte infusion Transplantation 03 medical and health sciences 0302 clinical medicine medicine.anatomical_structure Immune system Oncology Antigen 030220 oncology & carcinogenesis Immunology medicine Cytotoxic T cell business |
Zdroj: | International Journal of Cancer. 144:1135-1146 |
ISSN: | 0020-7136 |
Popis: | T cell responses against malignant cells play a major role in maintaining remission and prolonging overall survival in patients after allogeneic stem cell transplantation and donor lymphocyte infusion (DLI) due to graft-versus-leukemia effect. For better characterization of the T cell responses, we assessed frequency and diversity of leukemia-associated antigen (LAA)-specific cytotoxic T cells using ELISpot and pMHC multimer assays and analyzed the frequency of regulatory T cells (Treg) as well as cytokine profiles before/after DLI. The data were correlated to the clinical course of patients. Significantly more LAA-derived T cell epitopes (p = 0.02) were recognized in clinical responders (R) when compared to nonresponders (NR). In addition, pMHC multimer-based flow cytometry showed a significantly higher frequency of LAA-specific T cells in R versus NR. The frequency of Treg in R decreased significantly (p = 0.008) while keeping stable in NR. No differences in T cell subset analysis before/after DLI were revealed. Clinical responders were correlated to specific immune responses and all clinical responders showed an increase of specific immune responses after DLI. Cytokine assays using enzyme-linked immunosorbent assay showed a significant increase of IL-4 after DLI. Taken together, an increase of specific CTL responses against several LAA after DLI was detected. Moreover, this study suggests that enhanced LAA diversity in T cell responses as well as decreasing numbers of Treg contribute to clinical outcome of patients treated with DLI. |
Databáze: | OpenAIRE |
Externí odkaz: |